Earnings Call · Q2 FY2021·2021-08-05

Q2 21EPS +30.88%·Rev n/aQ1 21EPS -100.00%*·Rev n/aQ4 20EPS -10.53%·Rev n/aQ3 20EPS -29.08%·Rev n/a⚠ consensus missing

LISATA THERAPEUTICS, INC. LSTA

John Menditto — Vice President of Investor Relations

David Mazzo — President and Chief Executive Officer

James Nisco — Vice President

−1.6%1d on move date−1.7% vs SPY3d+1.6%5d−0.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LSTA calls or request research access.

More LSTA calls Browse calls Request research access